For Manchester patients managing chronic Hepatitis B, Tafsure represents the most advanced oral antiviral option, offering superior kidney and bone safety compared to older TDF-based medicines, particularly valuable for long-term lifelong therapy.
TAF achieves high concentrations within liver cells where HBV replicates, while keeping plasma drug levels low — reducing systemic side effects while maintaining full antiviral potency.
|
FAQ: Will I need to take Tafsure for the rest of my life? For most chronic Hepatitis B patients, yes — TAF-based therapy like Tafsure is typically a long-term or lifelong commitment, since it suppresses viral replication but does not eliminate the hepatitis B virus from the body entirely in most cases. Stopping treatment can cause viral rebound and liver inflammation flares. Some patients with strong immune control may eventually be considered for treatment discontinuation by their hepatologist, but this is assessed case-by-case with careful monitoring. |
